Semin intervent Radiol 2017; 34(02): 101-108
DOI: 10.1055/s-0037-1602590
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Decision Making for Selection of Transarterial Locoregional Therapy of Metastatic Neuroendocrine Tumors

Ron C. Gaba
1   Department of Radiology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois
2   Division of Interventional Radiology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois
,
Nasya Mendoza-Elias
3   College of Medicine, University of Illinois Hospital and Health Sciences System, Chicago, Illinois
,
Joseph D. Morrison
3   College of Medicine, University of Illinois Hospital and Health Sciences System, Chicago, Illinois
,
Ali Kord Valeshabad
1   Department of Radiology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois
,
Andrew J. Lipnik
1   Department of Radiology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois
2   Division of Interventional Radiology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois
› Author Affiliations
Further Information

Publication History

Publication Date:
01 June 2017 (online)

Preview

Abstract

Transarterial locoregional therapies (LRTs) are indispensable components of the modern interventional oncologic therapy of liver-dominant metastatic neuroendocrine tumors (NETs). The scope of available LRTs and their nuanced differences mandates a thorough understanding of their relative applicability and effectiveness in certain clinical circumstances to prescribe appropriate, patient-specific, image-guided therapy. This article aims to provide an overview of transarterial LRT options for liver-dominant metastatic NETs and therapy selection by reviewing procedure types, their advantages and disadvantages, and comparative efficacy in common case scenarios.